04.09.24|Golan HazaniTrustee to explore full or partial sale of Lusix as financial woes deepen.
23.08.24|Golan HazaniThe founder apologized for hardships and vowed to prioritize workers' welfare after the synthetic diamond company requested a stay of proceedings due to debts of around $28 million.
19.08.24|Golan HazaniThe company has submitted a request for a stay of proceedings to the court due to debts of about $28 million. According to the company, it needs six weeks to complete a merger with another company, after which shareholders will inject $22 million. Lusix has raised over $150 million to date.
17.01.24|Almog AzarThe Israeli company has been significantly hit by high interest rates and increased industry competition, resulting in an emergency funding round at a valuation of just $50 million
16.01.23|Benny Landa
20.06.22|Diana Bahur-NirSerial Israeli entrepreneur Benny Landa misses Indigo and his father, and hopes he’ll get to die at work
10.06.22|CTechThe company, founded by legendary entrepreneur Benny Landa, plans to use the investment to expand its production capacity in Israel with a second 100% solar-powered facility
25.08.21|Golan HazaniThe nanographic printing company has hired Bank of America and has been negotiating a potential merger with a SPAC over recent months
31.12.19|Avior AbouThe serial entrepreneur spoke at Calcalist’s Forecasts 2020 conference held Tuesday in Tel Aviv
04.10.19|Diana Bahur-NirThe printing multi-millionaire’s newest venture has him cooking diamonds in a central Israel lab, in a process he describes as “alchemy”
08.05.19|Hagar Ravet and Meir OrbachFive fascinating companies that lived up to their promise, became unicorns, and earned their way out of the ranking
16.02.18|Keren Tsuriel Harari and Asaf ShalevIn December, the Israeli parliament passed by a vote of 71 to 41 a plan to deport some 40,000 refugees and asylum seekers, primarily from Eritrea and Sudan
22.12.17|Omer KabirTech entrepreneur Benny Landa had sounded the alarm on the generic drugmaker as far back as 2013, but seeing his forecasts realized gives him no satisfaction
06.08.17|Golan HazaniTeva’s board was surprised to learn AstraZeneca's CEO Pascal Soriot will not be joining the company. Teva activist investor Benny Landa called an early report on Teva's negotiations with Mr. Soriot "devastating"